Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Описание к видео Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Professor Thomas Lüscher discusses the paper of the week with Brian Halliday
Sodium–glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction are uncertain.
#InsideCardiology

Комментарии

Информация по комментариям в разработке